Kee KM, Kim SH, Yang SY, Shin JU, et al. Comparison of 3-month cytogenetic and molecular assays for early assessment of long-term clinical impact after BCR-ABL1 tyrosine kinase inhibitor treatment in chronic myeloid leukemia. Leuk Res 2021;112:106754.
PMID: 34906861